| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/23/2007 | US7166693 Treating flea allergic dermatitis |
| 01/23/2007 | US7166640 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 01/23/2007 | US7166611 Plant extract comprising steroidal glycosides from the genus Trichocaulon or Hoodia produced by solvent extraction |
| 01/23/2007 | US7166568 Compositions and methods to inhibit formation of the C5b-9 complex of complement |
| 01/23/2007 | US7166450 Hyaluronan synthase gene and uses thereof |
| 01/23/2007 | US7166426 utilizing a first isolated antigen derived from a region of the hepatitis C virus polyprotein and a multiple epitope fusion antigen; for accurately diagnosing hepatitis C virus infection; solid phase synthesis |
| 01/23/2007 | US7166298 Genetic immunization with cationic lipids |
| 01/23/2007 | US7166291 Allergenic proteins and peptides from dog dander and uses therefor |
| 01/23/2007 | US7166290 Methods for producing oocysts |
| 01/23/2007 | US7166289 Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia |
| 01/23/2007 | US7166288 Can also be used to inhibit metastasis of any tumor cells released in the subject's blood circulation during a surgical resection of a tumor |
| 01/23/2007 | US7166287 Viral agent |
| 01/23/2007 | US7166286 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for prophylaxis and detection of cancers |
| 01/23/2007 | US7166285 Anti-IL-12 antibodies and compositions |
| 01/23/2007 | US7166284 Completitive binding; immunoassay, immunotherapy |
| 01/23/2007 | US7166283 Bind to AILIM (activation inducible lymphocyte immunomodulatory molecule, also referred to as ICOS (inducible co-stimulator); human monoclonal antibodies which bind to AILIM or a portion thereof; for treating disorders related to the delayed allergy |
| 01/23/2007 | US7166282 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2007 | CA2326389C Novel cd19xcd3 specific polypeptides and uses thereof |
| 01/23/2007 | CA2288045C A new class of benzoporphyrin derivative photoactive compounds |
| 01/23/2007 | CA2101104C Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumors |
| 01/18/2007 | WO2007009087A2 Methods and products for treatment of diseases |
| 01/18/2007 | WO2007009065A2 Methods of treating autoimmune disease using humanized anti-cd16a antibodies |
| 01/18/2007 | WO2007009064A2 Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity |
| 01/18/2007 | WO2007008918A2 Virus vaccines comprising envelope-bound immunomodulatory proteins and methods of use thereof |
| 01/18/2007 | WO2007008905A1 Porcine rotavirus reassortant compositions |
| 01/18/2007 | WO2007008712A2 Anti-alpha v beta 6 antibodies and uses thereof |
| 01/18/2007 | WO2007008691A2 Use of microchimeric cells in the treatment of malignancy |
| 01/18/2007 | WO2007008547A2 Sp35 antibodies and uses thereof |
| 01/18/2007 | WO2007008496A1 Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins |
| 01/18/2007 | WO2007008479A1 Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidar |
| 01/18/2007 | WO2007008463A2 Anti-ctla-4 antibody and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment |
| 01/18/2007 | WO2007008092A2 Diagnostic kit for the examination of animal sera for the presence of anti-rhd antibodies and a diagnostic kit for detecting the rhd virus |
| 01/18/2007 | WO2007008070A2 ADJUVATION THROUGH CROSS-β STRUCTURE |
| 01/18/2007 | WO2007007946A1 A vaccine composition comprising alpha-galactosylceramide as an adjuvatnt for intranasal administration |
| 01/18/2007 | WO2007007665A1 Therapeutic agent for arteriosclerosis |
| 01/18/2007 | WO2007007352A2 A vaccine for staphylococcal infections |
| 01/18/2007 | WO2007007344A1 Inactivated poliomyelitis vaccine derived from sabin strain of polio virus |
| 01/18/2007 | WO2007007162A1 New combination of anti-madcam antibody and antifibrotic caspase inhibitor to treat liver fibrosis |
| 01/18/2007 | WO2007007160A2 Anti-madcam antibodies to treat fever |
| 01/18/2007 | WO2007007159A2 Anti-madcam antibodies to treat uterine disorders |
| 01/18/2007 | WO2007007152A2 Anti-madcam antibodies to treat metastatic cancers and chloroma |
| 01/18/2007 | WO2007007151A2 Use of anti-mad-cam antibody for the treatment of emphysema |
| 01/18/2007 | WO2007007145A2 Use of anti-madcam antibodies for the treatment of coeliac disease and tropical sprue |
| 01/18/2007 | WO2007007086A2 Antibodies for anthrax |
| 01/18/2007 | WO2007006712A2 Mycoplasma subunit vaccine |
| 01/18/2007 | WO2007006581A2 Targeting lsd1 for use in identifying and/or scoring prostate cancer and for controlling anrogen receptor-dependent gene expression |
| 01/18/2007 | WO2007006573A2 Variant iaspp polypeptide and screening assay |
| 01/18/2007 | WO2007006101A1 Surface proteins of pasteurella multocida |
| 01/18/2007 | WO2006131953A3 Antibodies directed against the myelin basic protein recognising an epitope of cd64 and their use as immunosuppressants |
| 01/18/2007 | WO2006130621A3 Method of determining immune enhancement of virus infectivity using fc receptor-transfected cell lines |
| 01/18/2007 | WO2006128103A3 Humanized anti-cd40 antibodies and their methods of use |
| 01/18/2007 | WO2006125914A3 Use of h11 protein in in vitro diagnosis of streptococcus pyogenes infections |
| 01/18/2007 | WO2006125140A3 Methods for treating fibrotic conditions |
| 01/18/2007 | WO2006124689A3 Combination therapy |
| 01/18/2007 | WO2006117240A3 Novel method for preventing or treating m tuberculosis infection |
| 01/18/2007 | WO2006116660A3 Methods of inhibiting a gpr23 |
| 01/18/2007 | WO2006113526A3 Prevention of chlamydia infection using a protective antibody |
| 01/18/2007 | WO2006113308A8 Method for treating inflammatory bowel disease (ibd) by an anti-cd20 antibody |
| 01/18/2007 | WO2006105954A3 Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types |
| 01/18/2007 | WO2006088956A3 Methods of predicting therpeutic response in atopic dermatitis to il-31 antagonists |
| 01/18/2007 | WO2006086361A3 ANTILYMPHOCYTE ANTIBODY INDUCTION BY COMBINATION OF AN SlP RECEPTOR AGONIST/MODULATOR AND OF IMMUNOSUPPRESSIVE DRUGS |
| 01/18/2007 | WO2006073748A3 Antibodies against antigen presenting cells and uses thereof |
| 01/18/2007 | WO2006063101A3 Vaccines for the rapid response to pandemic avian influenza |
| 01/18/2007 | WO2006061723A3 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 01/18/2007 | WO2006056306A3 Hydrogel polymeric conjugates of a prodrug |
| 01/18/2007 | WO2005120638A8 Combination of radio waves and pharmacologically active substances |
| 01/18/2007 | WO2005112564A3 Germline and sequence variants of humanized antibodies and methods of making and using them |
| 01/18/2007 | WO2005107470A3 Use of carbonic anhydrase inhibitors for insect control and malaria treatment |
| 01/18/2007 | WO2005042695A3 Lipoparticles comprising proteins, methods of making, and using the same |
| 01/18/2007 | WO2004087047A3 Mutants of replication competent vaccinia virus |
| 01/18/2007 | WO2004084837A3 Methods and compositions for treating and preventing inflammatory conditions |
| 01/18/2007 | WO2004071468A3 Short immunomodulatory oligonucleotides |
| 01/18/2007 | WO2004048525A3 Therapy of non-malignant diseases or disorders with anti-erbb2 antibodies |
| 01/18/2007 | US20070015907 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 01/18/2007 | US20070015721 Hiv-gag codon-optimised dna vaccines |
| 01/18/2007 | US20070015704 Cancer drug target; useful in diagnostic, prophylactic, prognostic, of certain cancers |
| 01/18/2007 | US20070015258 Alpha-beta C4BP -type recombinant heteromultimeric proteins |
| 01/18/2007 | US20070015219 Specifically binds an MK61 polypeptide produced by immunizing an animal |
| 01/18/2007 | US20070015217 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of Alzheimer's disease |
| 01/18/2007 | US20070015199 Stabilized immunogenic HBc chimer particles |
| 01/18/2007 | US20070015173 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 01/18/2007 | US20070015161 Drug screening for mitotic inhibitor drugs; cancer |
| 01/18/2007 | US20070015150 Novel nucleic acid sequences and proteins of tumors and neoplasias of the thyroid gland |
| 01/18/2007 | US20070014842 Pharmaceutical liposomal compositions |
| 01/18/2007 | US20070014841 Pharmaceutical compositions |
| 01/18/2007 | US20070014817 Methods for detecting virulent Plasmodium, for evaluating Plasmodium virulence, and for screening new drugs employing the 3'UTR of Plasmodium SUB2 and the Plasmodium SUB2 serine protease |
| 01/18/2007 | US20070014816 such as a botulinum toxin; pain is not associated with a headache pain |
| 01/18/2007 | US20070014815 Lawsonia vaccine and methods of use thereof |
| 01/18/2007 | US20070014814 Webbed HIV envelope immunogens, methods for production and use of same |
| 01/18/2007 | US20070014813 Immunogenic polypeptide comprising adjuvant (alum); coupled to diphtheria toxoid; diagnosis and treatment |
| 01/18/2007 | US20070014812 Carrier proteins for vaccines |
| 01/18/2007 | US20070014810 Epitope based vaccines directed towards HPV; side effect reduction; vaccination |
| 01/18/2007 | US20070014809 B Cell Activation and Polypeptides Having CD14 Activity |
| 01/18/2007 | US20070014808 Vaccine composition comprising non-human, mammalian 5T4 antigen for prevention of cell proliferative disorders |
| 01/18/2007 | US20070014807 Multiplex vaccine |
| 01/18/2007 | US20070014806 Universally applicable blood plasma |
| 01/18/2007 | US20070014805 Immuno-adjuvant emulsion |
| 01/18/2007 | US20070014804 Peptidic nanoparticles as drug delivery and antigen display systems |
| 01/18/2007 | US20070014803 Methods and compositions for diagnosis and treatment of viral and bacterial infections |
| 01/18/2007 | US20070014802 Modified antibody fragments |